Microbot Medical Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-13.1M | $-11.4M | $-10.7M | $-13.2M | $-11.3M | $-9.2M | $-7.2M | $-7.3M |
| Depreciation & Amortization | $47.0K | $91.0K | $106.0K | $102.0K | $76.0K | $68.0K | $84.0K | $54.0K |
| Depreciation | — | — | — | — | — | — | — | $54.0K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $1.1M | $1.3M | $1.4M | $1.8M | $1.4M | $1.9M | $1.1M | $1.4M |
| Net Cash from Operating Activities | $-13.0M | $-8.8M | $-8.5M | $-11.5M | $-9.4M | $-7.3M | $-6.5M | $-5.3M |
| Investing Activities | ||||||||
| Capital Expenditures | $60.0K | $25.0K | $33.0K | $84.0K | $69.0K | $91.0K | $216.0K | $223.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-72.4M | $1.5M | $2.0M | $-3.8M | $3.2M | $-2.8M | $-2.5M | $-223.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $86.2M | $7.9M | $6.6M | $4.3M | — | $-3.4M | $36.8M | $-18.0K |
| Net Change in Cash | $810.0K | $646.0K | $-2.0K | $-11.1M | $-6.2M | $-13.4M | $27.9M | $-5.6M |
| Free Cash Flow | $-13.1M | $-8.9M | $-8.6M | $-11.6M | $-9.4M | $-7.3M | $-6.7M | $-5.5M |